Teva Eyes High Court as Drug-Patent Listings Face Scrutiny (1)
The Federal Circuit’s refusal to reconsider its ruling forcing Teva to delist asthma-inhaler patents from the FDA’s Orange ...
Teva Loses Bid to Have Patent-Delisting Decision Reheard (1)
Teva Pharmaceutical Industries Ltd. failed to convince the Federal Circuit to reconsider a December ruling that five patents ...
Is Teva Pharmaceuticals Industries Limited (TEVA) the Best Weight Loss Drug Stock to Buy According to Analysts?
We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going ...
Teva Pharmaceutical Industries Limited (TEVA) Presents at Barclays 27th Annual Global Healthcare Conference (Transcript)
Teva Pharmaceutical Industries Limited ( NYSE: TEVA) Barclays 27th Annual Global Healthcare Conference March 11, 2025 8:00 AM ET Good morning, everyone. My name is Balaji Prasad. I'm the Senior ...
This Is What Whales Are Betting On Teva Pharmaceutical Indus
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Teva ...
KLN Selected by Teva as its Exclusive 4PL Service Provider in the Greater Bay Area
Kerry Logistics Network Limited ('KLN'; Stock Code 0636.HK), through its subsidiary, Kerry Pharma, and Teva Pharmaceutical Hong Kong Limited ('Teva') entered into an exclusive agreement for ...
Brokerages Set Teva Pharmaceutical Industries Limited (NYSE:TEVA) Price Target at $23.57
Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report) have been assigned an average rating of ...
Bank of America Has Lowered Expectations for Teva Pharmaceutical Industries (NYSE:TEVA) Stock Price
Teva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) had its target price decreased by Bank of America from $23.00 to ...
sharewise13d
Teva Pharmaceutical Stock: Strategic Global Access Initiatives Advance
Teva Pharmaceutical Industries Ltd. continues to strengthen its global market position through strategic access initiatives ...
The Pharma Letter13d
Teva resumes scarce epilepsy drug Finlepsin retard deliveries to Russia
Israeli drug manufacturer Teva Pharmaceutical Industries has resumed the deliveries of the scarce epilepsy drug Finlepsin ...
Barclays Keeps Their Buy Rating on Ligand Pharma (LGND)
In a report released today, Balaji Prasad from Barclays maintained a Buy rating on Ligand Pharma (LGND – Research Report), with a price target ...
Nasdaq5d
This Is What Whales Are Betting On Teva Pharmaceutical Indus
Financial giants have made a conspicuous bullish move on Teva Pharmaceutical Indus. Our analysis of options history for Teva Pharmaceutical Indus (NYSE:TEVA) revealed 8 unusual trades. Delving ...